Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers
BackgroundPatients with multidrug-resistant tuberculosis (MDR-TB) face challenges adhering to medications, given that treatment is prolonged and has a high rate of adverse effects. The Medication Event Reminder Monitor (MERM) is a digital pillbox that provides pill-taking reminders and facilitates t...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2021-06-01
|
| Series: | Journal of Medical Internet Research |
| Online Access: | https://www.jmir.org/2021/6/e23294 |
| _version_ | 1818390447048884224 |
|---|---|
| author | Thomas, Beena E Kumar, J Vignesh Periyasamy, Murugesan Khandewale, Amit Subhash Hephzibah Mercy, J Raj, E Michael Kokila, S Walgude, Apurva Shashikant Gaurkhede, Gunjan Rahul Kumbhar, Jagannath Dattatraya Ovung, Senthanro Paul, Mariyamma Rajkumar, B Sathyan Subbaraman, Ramnath |
| author_facet | Thomas, Beena E Kumar, J Vignesh Periyasamy, Murugesan Khandewale, Amit Subhash Hephzibah Mercy, J Raj, E Michael Kokila, S Walgude, Apurva Shashikant Gaurkhede, Gunjan Rahul Kumbhar, Jagannath Dattatraya Ovung, Senthanro Paul, Mariyamma Rajkumar, B Sathyan Subbaraman, Ramnath |
| author_sort | Thomas, Beena E |
| collection | DOAJ |
| description | BackgroundPatients with multidrug-resistant tuberculosis (MDR-TB) face challenges adhering to medications, given that treatment is prolonged and has a high rate of adverse effects. The Medication Event Reminder Monitor (MERM) is a digital pillbox that provides pill-taking reminders and facilitates the remote monitoring of medication adherence.
ObjectiveThis study aims to assess the MERM’s acceptability to patients and health care providers (HCPs) during pilot implementation in India’s public sector MDR-TB program.
MethodsFrom October 2017 to September 2018, we conducted qualitative interviews with patients who were undergoing MDR-TB therapy and were being monitored with the MERM and HCPs in the government program in Chennai and Mumbai. Interview transcripts were independently coded by 2 researchers and analyzed to identify the emergent themes. We organized findings by using the Unified Theory of Acceptance and Use of Technology (UTAUT), which outlines 4 constructs that predict technology acceptance—performance expectancy, effort expectancy, social influence, and facilitating conditions.
ResultsWe interviewed 65 patients with MDR-TB and 10 HCPs. In patient interviews, greater acceptance of the MERM was related to perceptions that the audible and visual reminders improved medication adherence and that remote monitoring reduced the frequency of clinic visits (performance expectancy), that the device’s organization and labeling of medications made it easier to take them correctly (effort expectancy), that the device facilitated positive family involvement in the patient’s care (social influences), and that remote monitoring made patients feel more cared for by the health system (facilitating conditions). Lower patient acceptance was related to problems with the durability of the MERM’s cardboard construction and difficulties with portability and storage because of its large size (effort expectancy), concerns regarding stigma and the disclosure of patients’ MDR-TB diagnoses (social influences), and the incorrect understanding of the MERM because of suboptimal counseling (facilitating conditions). In their interviews, HCPs reported that MERM implementation resulted in fewer in-person interactions with patients and thus allowed HCPs to dedicate more time to other tasks, which improved job satisfaction.
ConclusionsSeveral features of the MERM support its acceptability among patients with MDR-TB and HCPs, and some barriers to patient use could be addressed by improving the design of the device. However, some barriers, such as disease-related stigma, are more difficult to modify and may limit use of the MERM among some patients with MDR-TB. Further research is needed to assess the accuracy of MERM for measuring adherence, its effectiveness for improving treatment outcomes, and patients’ sustained use of the device in larger scale implementation. |
| first_indexed | 2024-12-14T04:57:46Z |
| format | Article |
| id | doaj.art-584748067471466aa9c2fce3dd0aeffb |
| institution | Directory Open Access Journal |
| issn | 1438-8871 |
| language | English |
| last_indexed | 2024-12-14T04:57:46Z |
| publishDate | 2021-06-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | Journal of Medical Internet Research |
| spelling | doaj.art-584748067471466aa9c2fce3dd0aeffb2022-12-21T23:16:18ZengJMIR PublicationsJournal of Medical Internet Research1438-88712021-06-01236e2329410.2196/23294Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care ProvidersThomas, Beena EKumar, J VigneshPeriyasamy, MurugesanKhandewale, Amit SubhashHephzibah Mercy, JRaj, E MichaelKokila, SWalgude, Apurva ShashikantGaurkhede, Gunjan RahulKumbhar, Jagannath DattatrayaOvung, SenthanroPaul, MariyammaRajkumar, B SathyanSubbaraman, RamnathBackgroundPatients with multidrug-resistant tuberculosis (MDR-TB) face challenges adhering to medications, given that treatment is prolonged and has a high rate of adverse effects. The Medication Event Reminder Monitor (MERM) is a digital pillbox that provides pill-taking reminders and facilitates the remote monitoring of medication adherence. ObjectiveThis study aims to assess the MERM’s acceptability to patients and health care providers (HCPs) during pilot implementation in India’s public sector MDR-TB program. MethodsFrom October 2017 to September 2018, we conducted qualitative interviews with patients who were undergoing MDR-TB therapy and were being monitored with the MERM and HCPs in the government program in Chennai and Mumbai. Interview transcripts were independently coded by 2 researchers and analyzed to identify the emergent themes. We organized findings by using the Unified Theory of Acceptance and Use of Technology (UTAUT), which outlines 4 constructs that predict technology acceptance—performance expectancy, effort expectancy, social influence, and facilitating conditions. ResultsWe interviewed 65 patients with MDR-TB and 10 HCPs. In patient interviews, greater acceptance of the MERM was related to perceptions that the audible and visual reminders improved medication adherence and that remote monitoring reduced the frequency of clinic visits (performance expectancy), that the device’s organization and labeling of medications made it easier to take them correctly (effort expectancy), that the device facilitated positive family involvement in the patient’s care (social influences), and that remote monitoring made patients feel more cared for by the health system (facilitating conditions). Lower patient acceptance was related to problems with the durability of the MERM’s cardboard construction and difficulties with portability and storage because of its large size (effort expectancy), concerns regarding stigma and the disclosure of patients’ MDR-TB diagnoses (social influences), and the incorrect understanding of the MERM because of suboptimal counseling (facilitating conditions). In their interviews, HCPs reported that MERM implementation resulted in fewer in-person interactions with patients and thus allowed HCPs to dedicate more time to other tasks, which improved job satisfaction. ConclusionsSeveral features of the MERM support its acceptability among patients with MDR-TB and HCPs, and some barriers to patient use could be addressed by improving the design of the device. However, some barriers, such as disease-related stigma, are more difficult to modify and may limit use of the MERM among some patients with MDR-TB. Further research is needed to assess the accuracy of MERM for measuring adherence, its effectiveness for improving treatment outcomes, and patients’ sustained use of the device in larger scale implementation.https://www.jmir.org/2021/6/e23294 |
| spellingShingle | Thomas, Beena E Kumar, J Vignesh Periyasamy, Murugesan Khandewale, Amit Subhash Hephzibah Mercy, J Raj, E Michael Kokila, S Walgude, Apurva Shashikant Gaurkhede, Gunjan Rahul Kumbhar, Jagannath Dattatraya Ovung, Senthanro Paul, Mariyamma Rajkumar, B Sathyan Subbaraman, Ramnath Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers Journal of Medical Internet Research |
| title | Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers |
| title_full | Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers |
| title_fullStr | Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers |
| title_full_unstemmed | Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers |
| title_short | Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers |
| title_sort | acceptability of the medication event reminder monitor for promoting adherence to multidrug resistant tuberculosis therapy in two indian cities qualitative study of patients and health care providers |
| url | https://www.jmir.org/2021/6/e23294 |
| work_keys_str_mv | AT thomasbeenae acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT kumarjvignesh acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT periyasamymurugesan acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT khandewaleamitsubhash acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT hephzibahmercyj acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT rajemichael acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT kokilas acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT walgudeapurvashashikant acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT gaurkhedegunjanrahul acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT kumbharjagannathdattatraya acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT ovungsenthanro acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT paulmariyamma acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT rajkumarbsathyan acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders AT subbaramanramnath acceptabilityofthemedicationeventremindermonitorforpromotingadherencetomultidrugresistanttuberculosistherapyintwoindiancitiesqualitativestudyofpatientsandhealthcareproviders |